BSE Corporate News   

@BSE_News

BIOCON - Announcement under Regulation 30 (LODR)-Investor Presentation

21/09/2021 04:21:06 PM     Share:    

---

  PRADIP DE   

@PRADIPDE1

STRONGEST STOCK OF THE DAY, MY CALL BIOCON

21/09/2021 12:26:53 PM     Share:    

---

  kkonline.org   

@krishnakhanna

Pullback Sell #BIOCON 360.85 9/21/2021 10:10:00 AM SL: 364.05 T1(fibo): 342.98 T2(fibo): 334.93 T3(fibo): 326.88 #NimblrTA #Amibroker Alerts delayed for demo Preview Of #NimblrTA #Tools And #Resources Join on Telegram:

21/09/2021 10:13:58 AM     Share:    

---

  Economic Times   

@EconomicTimes

The Serum alliance would give Biocon Biologics' access to 100 million doses of vaccines per annum for 15 years with commercialisation rights, including that of Covid-19 vaccines, for global markets

20/09/2021 10:45:00 PM     Share:    

---

  ETMarkets   

@ETMarkets

The acquisition values Biocon Biologics 18 per cent higher than the value Saudi Arabia's ADQ paid in January for a 1.8 per cent stake in the Biocon subsidiary. Read more at:

20/09/2021 01:10:01 PM     Share:    

---

  Mint   

@livemint

The deal between Biocon Biologics and Serum Institute Life Sciences (SILS), under which the former will sell the latter’s vaccines every year globally in exchange for a 15% stake looks to be mutually beneficial. (@UjjvalJauhari reports)

20/09/2021 01:10:00 PM     Share:    

---

  ETMarkets   

@ETMarkets

Hold Biocon, target price Rs 410: ICICI Direct #ETMarkets #DailyRecos #StockPicks #DailyPicks

20/09/2021 12:41:18 PM     Share:    

---

  CNBC-TV18   

@CNBCTV18News

Sector In Focus | Discussing the Pharma sector & the stocks in focus, @NithyaBala84 of Sanford Bernstein says it is disappointing to see the US FDA issues at Lupin & that they see emerging concerns of a thinning pipeline for Biocon. @_soniashenoy, @SurabhiUpadhyay & @ekta_batra.

20/09/2021 12:28:53 PM     Share:    

---

  Investment Guru India   

@InvGurInd

Key News - Lupin Ltd, FDI, KEC International Ltd, Welspun India Ltd, Biocon By ARETE Securities #Lupin #Biocon #StockMarket #FDI #WelspunIndia #KECInternational #ARETESecurities #Investmentguruindia

20/09/2021 09:44:58 AM     Share:    

---

  ResearchPool   

@ResearchPool

Motilal Oswal - MOSL: Morning India (20/September/21): 1. Technology (AGIC takeaways - Growth outlook intact; supply-issues transitory); 2. Biocon (Adds Vaccines as a new growth dimension); 3. Lupin (USFDA issues seven observa: MOrning… #equity #stocks

20/09/2021 08:54:43 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

After the SII deal, revenue for Biocon, according to CLSA, will start accruing from H2FY23 with COVID vaccines; to generate a return, co needs minimum EBITDA of $1.5 m/dose, brokerage says, maintains a SELL call with target of Rs 260/sh

20/09/2021 08:36:51 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

Serum Institute deal will help Biocon complement its biosimilar biz; COVID vaccine demand sustenance beyond 2022 & pricing challenge are key risks for the stock, Morgan Stanley says. The brokerage has maintained an EQUAL-WEIGHT rating with target of Rs 371/sh

20/09/2021 08:36:42 AM     Share:    

---

  Ashish Verma   

@AshVerma111

#HouseViews On #BIOCON #MorganStanley Equal-Weight T=371 Serum Deal Will Help Co Compliment Its Bio-similar Biz COVID Vaccine Demand Sustenance Beyond 2022 & Pricing Challenge Key Risks #CLSA Sell, T=260/Sh Revenue To Start Accruing From H2'23 Needs Min EBITDA Of $1.5 m/Dose

20/09/2021 08:21:39 AM     Share:    

---

  CNBC-TV18   

@CNBCTV18Live

#CNBCTV18Market | After the SII deal, revenue for Biocon, according to CLSA, will start accruing from H2FY23 with COVID vaccines; to generate a return, co needs minimum EBITDA of $1.5 m/dose, brokerage says, maintains a SELL call with target of Rs 260/sh

20/09/2021 07:44:36 AM     Share:    

---

  CNBC-TV18   

@CNBCTV18Live

#CNBCTV18Market | Serum Institute deal will help Biocon complement its biosimilar biz; COVID vaccine demand sustenance beyond 2022 & pricing challenge are key risks for the stock, Morgan Stanley says. The brokerage has maintained an EQUAL-WEIGHT rating with target of Rs 371/sh

20/09/2021 07:44:29 AM     Share:    

---

  CNBC-TV18   

@CNBCTV18News

#ICYMI | Biocon Biologics to offer 15% stake to Serum Institute Life Sciences under a strategic alliance @BioconBiologics @kiranshaw @Bioconlimited @adarpoonawalla @SerumInstIndia #BioconBiologics #Biocon #SerumInstitute #SII #COVIDVaccines Read at:

18/09/2021 07:20:00 PM     Share:    

---

  ET Industry News   

@ETIndustryNews

Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccines #ETIndustryNews

18/09/2021 01:27:52 PM     Share:    

---

  ET Industry News   

@ETIndustryNews

Kiran Mazumdar-Shaw & Adar Poonawalla spell out the road map for Biocon-Serum alliance #ETIndustryNews

18/09/2021 01:27:41 PM     Share:    

---

  The New Indian Express   

@NewIndianXpress

Biocon Biologics Limited and Serum Institute Life Sciences Private Limited have come together with a strategic alliance in a bid to increase vaccines and antibody therapeutics access for developing countries.

18/09/2021 12:25:00 PM     Share:    

---

  BloombergQuint   

@BloombergQuint

Serum Institute expects tie-up with Biocon to yield ‘synergistic benefits’ Read more:

18/09/2021 11:15:00 AM     Share:    

---